The effect of the A1 AR antagonist, Prazosin on memory in an animal model of AD was studied previously, which showed that long-term use of Prazosin may slow the course of AD by increasing astrocytic proliferation, the release of anti-inflammatory cytokines, and the production of APOE [147]. Here, APOE is linked to Alzheimer disease.